Not Medicare Enrolled

Dr. Gregory Seymour, MD

Hematology & Oncology · Kingwood, TX
22710 PROFESSIONAL DR, Kingwood, TX 77339
2812988444
Registered in NPPES since 2006
NPI: 1720041056 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seymour from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seymour? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Seymour

Dr. Gregory Seymour is a hematology & oncology specialist in Kingwood, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Seymour received a total of $10,893 from 89 pharmaceutical and/or device companies across 632 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Seymour is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $10,893 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$10,893
Total received (2018-2023)
Avg $1,815/year across 6 years
Top 31% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
632
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$64
2022
$2,724
2021
$2,603
2020
$1,416
2019
$2,122
2018
$1,964

Payments by company (2023)

AbbVie Inc.
$50
Novo Nordisk Inc
$14
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$1,018
PFIZER INC.
$1,004
Janssen Biotech, Inc.
$810
Merck Sharp & Dohme Corporation
$613
E.R. Squibb & Sons, L.L.C.
$594
Astellas Pharma US Inc
$564
GENZYME CORPORATION
$396
Lilly USA, LLC
$367
GlaxoSmithKline, LLC.
$345
Seagen Inc.
$337
Amgen Inc.
$325
Celgene Corporation
$317
AstraZeneca Pharmaceuticals LP
$242
Incyte Corporation
$223
Gilead Sciences, Inc.
$209
Bayer HealthCare Pharmaceuticals Inc.
$159
Takeda Pharmaceuticals U.S.A., Inc.
$145
Pharmacyclics LLC, An AbbVie Company
$119
Teva Pharmaceuticals USA, Inc.
$112
TESARO, Inc.
$110
AbbVie Inc.
$107
Sandoz Inc.
$106
Boston Scientific Corporation
$104
Merck Sharp & Dohme LLC
$96
Ipsen Biopharmaceuticals, Inc
$93
Adaptive Biotechnologies Corporation
$85
Daiichi Sankyo Inc.
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
PUMA BIOTECHNOLOGY, INC.
$75
Genentech USA, Inc.
$73
Dova Pharmaceuticals
$72
MorphoSys, US Inc.
$71
Karyopharm Therapeutics Inc.
$67
AVEO Pharmaceuticals, Inc.
$67
Pharmacosmos Therapeutics Inc.
$67
EMD Serono, Inc.
$66
SERVIER PHARMACEUTICALS LLC
$61
JAZZ PHARMACEUTICALS INC.
$60
Exelixis Inc.
$54
AbbVie, Inc.
$53
Dendreon Pharmaceuticals LLC
$50
Taiho Oncology, Inc.
$49
Foundation Medicine, Inc.
$49
Mylan Institutional Inc.
$49
ABBVIE INC.
$47
Kite Pharma, Inc.
$45
Myovant Sciences Inc.
$43
Agios Pharmaceuticals, Inc.
$42
Seattle Genetics, Inc.
$42
Otsuka America Pharmaceutical, Inc.
$41
ARRAY BIOPHARMA INC
$37
TerSera Therapeutics LLC
$37
Eisai Inc.
$36
Servier Pharmaceuticals LLC
$34
Regeneron Healthcare Solutions, Inc.
$34
Janssen Pharmaceuticals, Inc
$34
Blue Earth Diagnostics Limited
$33
EISAI INC.
$33
Puma Biotechnology, Inc.
$30
Clovis Oncology, Inc.
$28
CTI BioPharma Corp.
$25
Aveo Pharmaceuticals, Inc.
$25
Heron Therapeutics, Inc.
$25
Sobi, Inc
$24
MEDIVATION FIELD SOLUTIONS LLC
$24
Acceleron Pharma, Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$22
Horizon Pharma plc
$22
Array BioPharma Inc.
$22
Acrotech Biopharma LLC
$21
Lantheus Medical Imaging, Inc.
$21
Immunomedics, Inc.
$20
Kyowa Kirin, Inc.
$20
Pharming Healthcare, Inc.
$19
ADC Therapeutics America, Inc.
$19
Genmab U.S., Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Spectrum Pharmaceuticals Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
Aurobindo Pharma USA, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
BeiGene USA, Inc.
$15
Novo Nordisk Inc
$14
Secura Bio, Inc.
$14
Emmaus Medical, Inc.
$12
Blueprint Medicines Corporation
$12
Sirtex Medical Inc
$11
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AVYCAZ · AYVAKIT · Abraxane · Aranesp · Axumin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Creon · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Endari · Erivedge · Erleada · FOTIVDA · FOUNDATIONONE · Farydak · Folotyn · Fulphila · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONUREG · OPDIVO · ORGOVYX · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Pomalyst · Prolia · Quadramet · RAYOS · REBLOZYL · RUCONEST · RYDAPT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEFLARO · TIBSOVO · TIVDAK · TRUSELTIQ · TUKYSA · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · Wegovy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · ZARXIO · ZEJULA · ZEPZELCA · ZIEXTENZO · ZOLADEX · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Kingwood?
Compare hematology & oncology specialists in the Kingwood area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
41
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
KINGWOOD PINES HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2023
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Seymour is a hematology & oncology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Seymour receive payments from pharmaceutical companies?
Yes. Dr. Seymour received a total of $10,893 from 89 companies across 632 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Seymour) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →